XBP Europe (XBP) said Wednesday it finalized its acquisition of Exela Technologies BPA, a business process automation firm. It expects the deal to raise its annual revenue to over $900 million.
Shares of XBP advanced 85% as intraday trading volume surged to over 136 million from a daily average of about 65,000.
Super X AI Technology (SUPX) reported Wednesday the launch of its latest AI server, powered by Nvidia's (NVDA) Blackwell architecture GPU (B200).
Shares surged 43% as intraday trading volume catapulted to over 5.03 million from a daily average of roughly 83,000.
BioNexus Gene Lab (BGLC) and Fidelion Diagnostics said they are partnering for liquid biopsy cancer monitoring and artificial intelligence-driven biotechnology.
BioNexus will acquire an equity stake in Fidelion and secure an exclusive commercial rights to its VitaGuard minimal-residual-disease platform in Southeast-Asia as part of the deal deal.
Shares of BioNexus rose 41% as intraday trading volume soared to over 54.8 million from a daily average of about 1.1 million.
Price: 1.70, Change: +0.80, Percent Change: +88.86
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.